SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-19-008474
Filing Date
2019-11-08
Accepted
2019-11-08 16:32:01
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_093019.htm 10-Q 493759
2 TONIX TRIMARAN APA ex10-01.htm EX-10.01 192619
3 TONIX WAYNE STATE FIRST AMENDED AND RESTATED EXCLUSIVE LICENSE ex10-02.htm EX-10.02 211797
4 SECOND COLUMBIA LICENSE ex10-03.htm EX-10.03 195915
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 16114
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 15387
7 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER ex32-01.htm EX-32.01 8350
  Complete submission text file 0001387131-19-008474.txt   3785459

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT tnxp-20190930.xml EX-101.INS 459621
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20190930.xsd EX-101.SCH 44200
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tnxp-20190930_cal.xml EX-101.CAL 39156
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tnxp-20190930_def.xml EX-101.DEF 174014
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20190930_lab.xml EX-101.LAB 333450
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20190930_pre.xml EX-101.PRE 248173
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 191204480
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences